» Articles » PMID: 32250340

Bacterial CagA Protein Compromises Tumor Suppressor Mechanisms in Gastric Epithelial Cells

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2020 Apr 7
PMID 32250340
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately half of the world's population is infected with the stomach pathogen Helicobacter pylori. Infection with H. pylori is the main risk factor for distal gastric cancer. Bacterial virulence factors, such as the oncoprotein CagA, augment cancer risk. Yet despite high infection rates, only a fraction of H. pylori-infected individuals develop gastric cancer. This raises the question of defining the specific host and bacterial factors responsible for gastric tumorigenesis. To investigate the tumorigenic determinants, we analyzed gastric tissues from human subjects and animals infected with H. pylori bacteria harboring different CagA status. For laboratory studies, well-defined H. pylori strain B128 and its cancerogenic derivative strain 7.13, as well as various bacterial isogenic mutants were employed. We found that H. pylori compromises key tumor suppressor mechanisms: the host stress and apoptotic responses. Our studies showed that CagA induces phosphorylation of XIAP E3 ubiquitin ligase, which enhances ubiquitination and proteasomal degradation of the host proapoptotic factor Siva1. This process is mediated by the PI3K/Akt pathway. Inhibition of Siva1 by H. pylori increases survival of human cells with damaged DNA. It occurs in a strain-specific manner and is associated with the ability to induce gastric tumor.

Citing Articles

Potential mechanism of traditional Chinese medicine intervention in gastric cancer: targeted regulation of autophagy.

Sun S, Yu W, Zhang G, Li X, Song L, Lv Y Front Pharmacol. 2025; 16:1548672.

PMID: 40066330 PMC: 11891941. DOI: 10.3389/fphar.2025.1548672.


AhR Activation Transcriptionally Induces Anti-Microbial Peptide Alpha-Defensin 1 Leading to Reversal of Gut Microbiota Dysbiosis and Colitis.

Palrasu M, Kakar K, Marudamuthu A, Hamida H, Thada S, Zhong Y Gut Microbes. 2025; 17(1):2460538.

PMID: 39894796 PMC: 11792800. DOI: 10.1080/19490976.2025.2460538.


H. Pylori-Facilitated TERT/Wnt/β-Catenin Triggers Spasmolytic Polypeptide-Expressing Metaplasia and Oxyntic Atrophy.

He L, Zhang X, Zhang S, Wang Y, Hu W, Li J Adv Sci (Weinh). 2024; 12(3):e2401227.

PMID: 39587848 PMC: 11744579. DOI: 10.1002/advs.202401227.


An antibiotic-free platform for eliminating persistent infection without disrupting gut microbiota.

Lai Y, Zhang T, Yin X, Zhu C, Du Y, Li Z Acta Pharm Sin B. 2024; 14(7):3184-3204.

PMID: 39027245 PMC: 11252519. DOI: 10.1016/j.apsb.2024.03.014.


Interaction between intestinal flora and gastric cancer in tumor microenvironment.

Yang M Front Oncol. 2024; 14:1402483.

PMID: 38835386 PMC: 11148328. DOI: 10.3389/fonc.2024.1402483.


References
1.
Wei J, Noto J, Zaika E, Romero-Gallo J, Piazuelo M, Schneider B . Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut. 2014; 64(7):1040-8. PMC: 4312278. DOI: 10.1136/gutjnl-2014-307295. View

2.
Peek Jr R . Helicobacter pylori strain-specific modulation of gastric mucosal cellular turnover: implications for carcinogenesis. J Gastroenterol. 2002; 37 Suppl 13:10-6. DOI: 10.1007/BF02990093. View

3.
Wang X, Zha M, Zhao X, Jiang P, Du W, Tam A . Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase. Nat Commun. 2013; 4:1551. DOI: 10.1038/ncomms2533. View

4.
Fortin A, MacLaurin J, Arbour N, Cregan S, Kushwaha N, Callaghan S . The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem. 2004; 279(27):28706-14. DOI: 10.1074/jbc.M400376200. View

5.
Teh M, Tan K, Seet B, Yeoh K . Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis. Cancer. 2002; 95(3):499-505. DOI: 10.1002/cncr.10697. View